Copyright
©The Author(s) 2023.
World J Hepatol. Oct 27, 2023; 15(10): 1091-1108
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1091
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1091
Table 2 Glycosides improve hepatic fibrosis by inhibiting oxidative stress
No. | Glycosides | Model | Upregulated molecules | Downregulated molecules | Mechanism | Ref. |
1 | Wogonoside | Rat | SOD, GSH, IL-10 | HA, LN, HYP, MDA, TNF-α, IL-1β, IL-6, TGF-β, MMP-2/9, Smad-3, PI3K/Akt/mTOR, NF-κB p65, PI3K/Akt/mTOR/p70S6K, α-SMA, Col-I | Inhibition of OS can improve hepatic fibrosis | Wang et al[126] |
2 | Hyperoside | Mice | SOD, GSH-Px, CAT, GSH, Nrf2 | GOT, GPT, MDA, TGF-β, Col-I/III | Activating Nrf2 nuclear translocation, inhibiting OS to increase antioxidant and phase II detoxifying enzyme activity can improve hepatic fibrosis | Zou et al[127] |
3 | Forsythiaside A | Mice | SOD, GSH, CAT, GSH-Px, p450 7a1, FXR, SHP, LRH-1, BSEP, NTCP, OATP-1 | HA, LN, PC-III, Col-I/IV, HYP, α-SMA, TNF-α, IL-1β, IL-6, LCA, DCA, HDCA, β-MCA, alloLCA, NorDCA, NorCA, CA, FGF-R4, MRP-2 | Inhibiting OS and inflammation, regulating gut microbiota and BA metabolism can improve hepatic fibrosis | Fu et al[128] |
- Citation: Li Z, Zhu JF, Ouyang H. Progress on traditional Chinese medicine in improving hepatic fibrosis through inhibiting oxidative stress. World J Hepatol 2023; 15(10): 1091-1108
- URL: https://www.wjgnet.com/1948-5182/full/v15/i10/1091.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i10.1091